Autoliv ALV Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross

Research And Development Arrangement Contract To Perform For Others Costs Incurred Gross at other companies

GlaukosGKOS

$2.5M-16.7%

AlkermesALKS

$0—

InsmedINSM

$8.62M-28.9%

InsmedINSM

$32.68M+16.4%

ViasatVSAT

11%0.0pp

CognexCGNX

$10.33M+4.0%

Other financials

Income statement

See full

Revenue$2.8B+6.8%

Gross profit$526.0M+10.0%

Operating income$237.0M-6.7%

Net income$141.0M-15.6%

EPS (diluted)$1.88-12.1%

Balance sheet

See full

Cash & equivalents$342.0M+6.2%

Total debt$2.3B-0.7%

Total equity$2.6B+12.0%

Total assets$8.5B+4.4%

Cash flow

See full

Operating cash flow-$76.0M-199%

CapEx$85.0M-16.7%

Free cash flow-$161.0M-544%

Valuation

See full

Market cap$8.85B+15.0%

Enterprise value$10.76B+11.3%

P/E12.5×+1.3×

P/S0.8×+0.1×

Profitability

See full

Gross margin19.3%+0.3pp

Operating margin9.7%-0.3pp

Net margin6.5%-0.2pp

FCF margin5.3%+0.7pp

Returns & leverage

See full

Return on equity28.4%-0.3pp

Debt / equity0.9×-0.1×

Current ratio1.1×+0.1×

Where this comes from

Reported directly by Autoliv in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross.

The official record: Autoliv’s 10-Q, filed April 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Autoliv's research and development arrangement contract to perform for others costs incurred gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Autoliv's research and development arrangement contract to perform for others costs incurred gross?: Autoliv (ALV) reported research and development arrangement contract to perform for others costs incurred gross of $163M in Q1 2026.
How has Autoliv's research and development arrangement contract to perform for others costs incurred gross changed year-over-year?: Autoliv's research and development arrangement contract to perform for others costs incurred gross increased by 10.9% year-over-year, from $147M to $163M.